Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") issued a report on its financial performance for the initial quarter of 2026, concluded on March 31. The update comes subsequent to the sale of its Biosecurity division. On May 7, 2026, the company provided insights into its first-quarter results post the divestment. This announcement comes amidst a changing business landscape for Ginkgo as it navigates new strategic directions.